References
1. Stenchever M, Droegemueller W, Herbst A, et al. Comprehensive Gynecology. St Louis, MO, Mosby, 2001.
2. Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol 2000;43:162–183.
3. Bair Y, Gold E, Greendale G, et al. Ethnic differences in use of complementary and alternative medicine at midlife: longitudinal results from SWAN participants. Am Public Health Assoc2002;11:1832–1840.
4. Kam I, Dennehy C, Tsourounis C. Dietary supplement use among menopausal women attending a San Francisco health conference. Menopause 2002;9:72–78.
5. Newton K, Buist D, Keenan N, et al. Use of alternative therapies for menopause symptoms: results of a population-based survey. Obstet Gynecol 2002;100:18–25.
6. Keenan N, Mark S, Fugh-Berman A, et al. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10:507–515.
7. Hunter M. Predictors of menopausal symptoms: psychosocial aspects. Baillieres Clin Endocrinol Metab 1993;7:33–45.
8. Hunter M, O’Dea I. An evaluation of a health education intervention for mid-aged women: five year follow-up of effects upon knowledge, impact of menopause and health. Patient Educ Counsel1999;38:249–255.
9. Balk J. Mind-body approaches to menopausal symptoms. Altern Ther Womens Health 2003;5:9–12.
10. Swartzman L, Edelberg R, Kemmann E. Impact of stress on objectively recorded menopausal hot flushes and on flush report bias. Health Psychol 1990;9:529–545.
11. Geramaine L, Freedman R. Behavioral treatment for menopausal hot flashes: evaluation by objective methods. J Consult Clin Psychol 1984;52:1072–1079.
12. Stevenson D, Delprato DJ. Multiple component self-control program for menopausal hot flashes. J Behav Ther Exp Psychiatry 1983;14:137–140.
13. Freedman R, Woodward S. Behavioral treatment for menopausal hot flashes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992;167:436–439.
14. Hunter M, Liao K-M. Determinants of treatment choice for menopausal hot flashes; hormonal versus psychological versus no treatment. J Psychosom Obstet Gynecol 1995;16:101–108.
15. Irvin J, Domar A, Clark C, et al. The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynecol 1996;17:202–207.
16. Wijma K, Melin A, Nedstrand E, et al. Treatment of menopausal symptoms with applied relaxation: a pilot study. Pergamon 1997;28:251–261.
17. Younus J, Simpson I, Collins A, et al. Mind control of menopause. Womens Health Issues2003;13:74–78.
18. Bass S, Pearce G, Bradney M, et al. Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Mineral Res1998;13:500–507.
19. Beck B, Snow C. Bone health across the lifespan: exercising our options. Exerc Sport Sci Rev2003;31:117–122.
20. Eden K, Orleans C, Mulrow C, et al. Does counseling by clinicians improve physical activity? A summary of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:E208–E215.
21. Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation. Health Psychol1997;16:203–208.
22. Stadberg E, Mattsson L, Milsom I. Factors associated with climacteric symptoms and the use of hormone replacement therapy. Acta Obstet Gynecol Scand 2000;79:286–292.
23. Aiello E, Yasui Y, Tworoger S, et al. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause2004;11:382–388.
24. Finn S. Women in Midlife: A nutritional perspective. J Womens Health Gender-Based Med2000;9:351–356.
25. Albert A, Altabre C, Baro F, et al. Beneficial effects and good tolerability of soy for menopausal symptoms. Phytomedicine 2002;9:85–92.
26. Han X, Soares J, Haidar M, et al. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002;99:389–394.
27. Van Patten C, Olivotto I, Chambers K, et al. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol2002;20:1449–1455.
28. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6–10.
29. Murkies A, Lombard C, Strauss B, et al. Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitus 1995;21:189–195.
30. Chen Y, Ho S, Lam S, et al. Soy Isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003;88:4740–4747.
31. Kritz-Silverstain D, Von Muhlen D, Barrett-Connor E, et al. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause 2003;10:196–202.
32. Cassidy A, Griffin B. Phyto-oestrogens: a potential role in the prevention of CHD? Proc Nutr Soc1999;58:193–199.
33. Horn-Ross P, John E, Canchola A, et al. Phytoestrogen intake and endometrial cancer risk. J Natl Cancer Inst 2003;95:1158–1164.
34. Kurzer M. Phytoestrogen Supplement Use by Women. Paper presented at NIH Dietary Supplement Use in Women: Current Status and Future Directions; January 28-29, 2002; Bethesda, MD.
35. Gass M, Taylor M. Alternatives for women through menopause. Alt J Obstet Gynecol2001;185:S47–S56.
36. Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 2002;137:805–813.
37. Lowdog T. Menopause. Foundations Herb Med 2000;47–54.
38. Harvey J, Zobitz M, Pak C. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988;3:253–258.
39. Heaney R, Dowell M, Barger-Lux M. Absorption of calcium as the carbonate and citrate salts, with some observations on method. Osteoporos Int 1999;9:19–23.
40. Reid I. Therapy of osteoporosis: calcium, vitamin d, and exercise. Am J Med Sci 1996;312:278–286.
41. Sakhaee K, Poindexter J, Griffith C, et al. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol 2004;172:958–961.
42. Ruml L, Sakhaee K, Peterson R, et al. The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized placebo-controlled study. Am J Ther 1999;6:303–311.
43. Lemay A, Dodin S, Kadri N, et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002;100:495–504.
44. Lehmann-Willenbrock E, Riedel H. Clinical and endocrinologic examinations about therapy of climacteric symptoms following hysterectomy with remaining ovaries. Zentralbl Gynakol 1988;110:611–618.
45. Liske E, Wustenberg P. Therapy of climacteric complaints with cimicifuga racemosa: herbal medicine with clinically proven evidence. Menopause 1998;5:250.
46. Stoll W. phytopharmacon influences atrophic vaginal epithelium: double-blind study: cimicifuga vs estrogenic substances. Therapeuticum 1987;1:23–31.
47. Warnecke G. Influence of a phytopharmaceutical on climacteric complaints. Die Meizinisch Welt1985;36:871–874.
48. Duker E, Kpanski L, Jarry H, et al. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 1991;57:420–424.
49. Jacobson J, Troxel A, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001;19:2739–2745.
50. Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44(Suppl 1):S59–S65.
51. McKenna D, Jones K, Humphrey S, et al. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. Altern Ther Health Med 2001;7:93–98.
52. Pepping J. Black cohosh: Cimicifuga racemosa. Am J Health Syst Pharm 1999;56:1400–1402.
53. Borrelli F, Izzo A, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sci 2003;73:1215–1229.
54. Klein K, Janfaza M, Wong J, et al. Estrogen bioactivity in fo-ti and other herbs used for their estrogen-like effects as determined by a recombinant cell bioassay. J Clin Endocrinol Metab2003;88:4077–4079.
55. Bodinet C, Freudenstin J. Influence of marketed herbal menopause preparations on MCF-7 cell proliferation. Menopause 2004;11:281–289.
56. Tice J, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study. JAMA 2003;290:207–214.
57. Baber R, Templeman C, Morton T, et al. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999;2:85–92.
58. Jeri A. the use of an isoflavone supplement to relieve hot flashes. Female Patient 2002;27:35–37.
59. Knight D, Howes J, Eden J. The effect of Promensil, and isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79–84.
60. van de Weijer P, Barentsen R. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002;42:187–193.
61. Nestle P, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women [erratum appears in J Clin Endocrinol Metab1999;84:3647]. J Clin Endocrinol Metab 1999;84:895–898.
62. Clifton-Bligh P, Baber R, Fulcher G, et al. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 2001;8:259–265.
63. Howes J, Bray K, Lorenz L, et al. The effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal women. Climacteric 2004;7:70–77.
64. Atkinson C, Warren R, Sala E, et al. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165]. Breast Cancer Res2004;6:R170–R179.
65. Hirata J, Swiersz L, Zell B, et al. does dong quai have estrogenic effects in post menopausal women? Fertil Steril 1997;68:981–986.
66. Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994;308:501–503.
67. Chopin L. Vitex agnus castus essential oil and menopausal balance: a research update. Comp Ther Nurs Midwife 2003;8:148–154.
68. Lucks B, Sorensen J, Veal L. Vitexagnus-castus essential oil and menopausal balance: a self-care survey. Comp Ther Nurs Midwife 2002;8:148–154.
69. Komesaroff P, Black C, Cable V, et al. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001;4:114–150.
70. Rakel D. Menopause, in Bralow L, Merahn S (eds): Integrative Medicine. Philadelphia, PA, Saunders, 2003, pp 367–370.
71. Taylor M. Unconventional estrogens: Estriol, Biest, and Triest. Clin Obstet Gynecol 2001;44:864–879.
72. Fugate S, Church C. Nonestrogen treatment modalities for vasomotor symptoms associated with menopause. Ann Pharmacother 2004;38:1482–1499.
73. Morelli V, Naquin C. alternative therapies for traditional disease states: menopause. Am Fam Physician 2002;66:129–134.